Compare Caesars Entertainment Inc (CZR) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Caesars Entertainment Inc vs Twist Bioscience Corp — how do they compare? Caesars Entertainment Inc trades at $30.29 (market cap $6.08B), while Twist Bioscience Corp trades at $93 (market cap $5.77B). The key difference: Caesars Entertainment Inc and Twist Bioscience Corp are close in size by market cap, and Caesars Entertainment Inc is trading nearer its 52-week high, Twist Bioscience Corp nearer its low. Which is the better fit depends on your goals.
| CZR | TWST | |
|---|---|---|
Market Cap | $6.08B | $5.77B |
Sector | Consumer Cyclical | Health |
52-Week High | $30.41 | $102.88 |
52-Week Low | $18.14 | $24.16 |
Enterprise Value | $30.14B | $5.69B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Caesars Entertainment (CZR) trades at $29.66, down 0.6% on the day, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company faces fundamental challenges with three consecutive quarterly earnings misses and negative net income margins, though valuation ratios appear attractive with P/E of 10.42 and P/S of 0.53. Recent developments include the opening of Caesars Republic Lake Tahoe and a pending $17.6 billion acquisition by Fertitta Entertainment.
CZR presents a complex investment case with analyst consensus leaning cautious (33% buy, 67% hold) despite a $31.27 price target suggesting modest upside. The pending acquisition provides a potential floor, but ongoing profitability challenges and competitive pressures in the gaming sector warrant careful monitoring of Q2 2026 earnings due July 28, 2026.
TWST trades at $90.35, down 0.31% on the day, with a bullish technical signal supported by moving averages and oversold RSI levels near key support at $89. Revenue growth remains strong, reaching $376.57M in 2025, though the company continues to report net losses. Recent news highlights AI-driven drug discovery collaborations and insider selling activity, while analyst consensus leans bullish with a $91.63 price target.
The stock offers growth exposure to synthetic biology and AI-enabled therapeutics, but carries significant risk due to persistent negative cash flow and profitability challenges. Investor sentiment is cautiously optimistic, balancing innovation potential against financial sustainability concerns in a competitive biotech landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Caesars Entertainment Inc
Caesars Entertainment includes around 50 domestic gaming properties across Las Vegas (50% of 2021 EBITDAR before corporate and digital expenses) and regional (63%) markets. Additionally, the company hosts managed properties and digital assets, the later of which produced material EBITDA losses in 2021. Caesars' U.S. presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the U.S. portion of William Hill (it plans to sell the international operation in 2022), a digital sports betting platform.
Read more on CZR →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
